NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have resulted in full survival of lethally infected animals was achieved.
A Novel Broad-Spectrum Antiviral with Activity Against RSV Read More »
Caris Life Sciences® announced that the company and collaborators from the biopharma industry and leading cancer centers, including those within the Caris Precision Oncology Alliance™, will collectively present 41 studies across 19 tumor types at the 2024 American Society of Clinical Oncology Annual Meeting May 31 to June 4, 2024.
En el reino animal, los mamíferos más altos destacan por su imponente presencia y su capacidad para dominar los paisajes más vastos de nuestro planeta. Desde las majestuosas jirafas que pueblan las sabanas africanas hasta los poderosos elefantes que deambulan por las selvas y ll …
Los mamíferos más altos: Gigantes de la naturaleza Read More »
Los vertidos radiactivos representan uno de los desafíos ambientales más críticos de nuestra era. La contaminación del suelo con materiales radioactivos no solo amenaza la salud humana y la biodiversidad, sino que también plantea un problema complejo y de largo pla …
Descontaminación de suelos con vertidos radiactivos Read More »
Meditrina, a leading innovator in gynecologic medical devices, announces the successful receipt of UKCA Mark, and CE Mark approval in accordance with Regulation 20147/745, for its state-of-the-art Aveta Hysteroscopy System.
Meditrina Announces CE Mark Approval and First Multi-International Cases Performed Read More »
Meditrina, a leader in gynecologic medical devices, announced the expansion of its leadership team with the hiring of Ray Gerena, as Senior Vice President of Global Sales.
Allozymes, a leading innovator in enzyme discovery and engineering, announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore.
Biophytis SA announces the design of its phase 2 OBA clinical study in obesity with BIO101.
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity Read More »
Vicore Pharma Holding AB, a clinical-stage biopharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists, is pleased to announce the election of Hans Schikan, PharmD, as the new Chair of the Board of Directors as well as the election of two new Board members, Ann Barbier,
Vicore Expands and Strengthens its Board of Directors Read More »
En los rincones más remotos de la Tierra, desde los océanos hasta los desiertos, las cianobacterias, también conocidas como algas verdeazuladas o cianoprokariotas, desempeñan un papel fundamental en la ecología global y la evolución de la vida en nuestro pla …
Cianobacterias: Los pioneros microscópicos de la vida Read More »
